This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cheng, K. Articles by Raufman, J.-P. Search for Related Content PubMed PubMed Citation Articles by Cheng, K. Articles by Raufman, J.-P.

Transactivation of the Epidermal Growth Factor Receptor Mediates Cholinergic Agonist-Induced Proliferation of H508 Human Colon Cancer Cells¹

Division of Gastroenterology, VA Maryland Health Care System and Program in Oncology, University of Maryland Greenebaum Cancer Center, Baltimore, Maryland 21201 [K. C., J-P. R.], and Central Arkansas Veterans Healthcare System and Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205 [P. Z.]

Some human colon cancer cell lines (e.g., H508 cells) express M3 subtype muscarinic receptors that are activated by cholinergic agonists. The objective of the present study was to determine the cellular mechanisms underlying M3 muscarinic receptor-mediated proliferation of H508 human colon cancer cells. In H508 cells, but not in SNU-C4 cells that do not express muscarinic receptors, acetylcholine stimulated calcium-dependent phosphorylation of p44/42 mitogen-activated protein kinase (MAPK) and p90 ribosomal S6 kinase and consequent cell proliferation. Atropine or inhibitors of MAPK phosphorylation blocked these effects. Conversely, the actions of epidermal growth factor (EGF) on H508 cells were neither calcium dependent nor mediated by cholinergic mechanisms. Both acetylcholine- and EGF-induced phosphorylation of p44/42 MAPK was abolished in the presence of EGF receptor (EGFR) inhibitors (AG1478 and PD168393). In Chinese hamster ovary cells transfected with the rat M3 muscarinic receptor, which lack EGFR, acetylcholine-induced MAPK phosphorylation was not altered in the presence of EGFR inhibitors. In H508 cells, protein kinase C inhibitors did not alter acetylcholine- or EGF-induced MAPK phosphorylation. Finally, inhibition of EGFR activation abolished acetylcholine-induced H508 cell proliferation. These data indicate that, in H508 human colon cancer cells, cholinergic ligand interaction with M3 muscarinic receptors results in transactivation of EGFR, thereby stimulating cellular proliferation.

This article has been cited by other articles:

				G. Xie, K. Cheng, J. Shant, and J.-P. Raufman Acetylcholine-induced activation of M3 muscarinic receptors stimulates robust matrix metalloproteinase gene expression in human colon cancer cells Am J Physiol Gastrointest Liver Physiol, April 1, 2009; 296(4): G755 - G763. [Abstract] [Full Text] [PDF]

				N. Shah, S. Khurana, K. Cheng, and J.-P. Raufman Muscarinic receptors and ligands in cancer Am J Physiol Cell Physiol, February 1, 2009; 296(2): C221 - C232. [Abstract] [Full Text] [PDF]

				K. Cheng, R. Samimi, G. Xie, J. Shant, C. Drachenberg, M. Wade, R. J. Davis, G. Nomikos, and J.-P. Raufman Acetylcholine release by human colon cancer cells mediates autocrine stimulation of cell proliferation Am J Physiol Gastrointest Liver Physiol, September 1, 2008; 295(3): G591 - G597. [Abstract] [Full Text] [PDF]

				J.-P. Raufman, R. Samimi, N. Shah, S. Khurana, J. Shant, C. Drachenberg, G. Xie, J. Wess, and K. Cheng Genetic Ablation of M3 Muscarinic Receptors Attenuates Murine Colon Epithelial Cell Proliferation and Neoplasia Cancer Res., May 15, 2008; 68(10): 3573 - 3578. [Abstract] [Full Text] [PDF]

				P. Song, H. S. Sekhon, A. Lu, J. Arredondo, D. Sauer, C. Gravett, G. P. Mark, S. A. Grando, and E. R. Spindel M3 Muscarinic Receptor Antagonists Inhibit Small Cell Lung Carcinoma Growth and Mitogen-Activated Protein Kinase Phosphorylation Induced by Acetylcholine Secretion Cancer Res., April 15, 2007; 67(8): 3936 - 3944. [Abstract] [Full Text] [PDF]

				P. Martinez-Moreno, S. Nieto-Ceron, J. Torres-Lanzas, F. Ruiz-Espejo, I. Tovar-Zapata, P. Martinez-Hernandez, J. N. Rodriguez-Lopez, C. J. Vidal, and J. Cabezas-Herrera Cholinesterase activity of human lung tumours varies according to their histological classification Carcinogenesis, March 1, 2006; 27(3): 429 - 436. [Abstract] [Full Text] [PDF]

				J. S. Heo, Y. J. Lee, and H. J. Han EGF stimulates proliferation of mouse embryonic stem cells: involvement of Ca2+ influx and p44/42 MAPKs Am J Physiol Cell Physiol, January 1, 2006; 290(1): C123 - C133. [Abstract] [Full Text] [PDF]

				D. Darmoul, V. Gratio, H. Devaud, F. Peiretti, and M. Laburthe Activation of Proteinase-Activated Receptor 1 Promotes Human Colon Cancer Cell Proliferation Through Epidermal Growth Factor Receptor Transactivation Mol. Cancer Res., September 1, 2004; 2(9): 514 - 522. [Abstract] [Full Text] [PDF]

				I. Tegeder and G. Geisslinger Opioids As Modulators of Cell Death and Survival--Unraveling Mechanisms and Revealing New Indications Pharmacol. Rev., September 1, 2004; 56(3): 351 - 369. [Abstract] [Full Text] [PDF]

				D. Darmoul, V. Gratio, H. Devaud, and M. Laburthe Protease-activated Receptor 2 in Colon Cancer: TRYPSIN-INDUCED MAPK PHOSPHORYLATION AND CELL PROLIFERATION ARE MEDIATED BY EPIDERMAL GROWTH FACTOR RECEPTOR TRANSACTIVATION J. Biol. Chem., May 14, 2004; 279(20): 20927 - 20934. [Abstract] [Full Text] [PDF]